[Tolerability and side effects of interferon alpha in the treatment of chronic viral hepatitis]. 1995

V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
Università degli Studi di Roma La Sapienza, Cattedra di Medicina Interna.

It is reported a review on side effects and toxicity of alfa interferon in treatment of chronic viral hepatitis. The clinical experience in 44 patients affected by chronic hepatitis and treated with 3MU of alfa interferon is analysed.

UI MeSH Term Description Entries
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
March 1995, Minerva gastroenterologica e dietologica,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
January 1994, Revista de gastroenterologia de Mexico,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
September 1997, Hepatology (Baltimore, Md.),
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
January 2006, Journal of hepatology,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
December 2000, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
September 1994, La Revue du praticien,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
November 1998, European journal of gastroenterology & hepatology,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
April 1993, Journal of hepatology,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
January 1995, Haemophilia : the official journal of the World Federation of Hemophilia,
V Paoletti, and G Galeotta, and A Mammarella, and L Donnarumma, and G Labbadia, and A De Matteis, and A Musca
December 1988, Hepato-gastroenterology,
Copied contents to your clipboard!